Evidence map›Paper›PMID 17997086›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2008

A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.

Mary C Farach-Carson, Anissa J Brown, Megan Lynam, Jeffrey B Safran, Daniel D Carson

Open access · greenAbstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Bioengineering in salivary gland regeneration.Journal of biomedical science · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. The nature and biology of basement membranes.Matrix biology : journal of the International Society for Matrix Biology · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.Matrix biology : journal of the International Society for Matrix Biology · 2014
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mary C Farach-CarsonDepartment of Biological Sciences, University of Delaware, Newark, DE 19716, USA. farachca@udel.edu
Anissa J Brown
Megan Lynam
Jeffrey B Safran
Daniel D Carson
University of Delaware · US

Funding

Prostate Cancer Bone Metastasis: Biology and TargetingP01CA098912 · NCI · EMORY UNIVERSITY · PI ZAYZAFOON, MAJD · 2003 to 2019
$24.0M
VALGUS BRACING FOR MEDIAL LAXITY IN PATIENTS WITH OSTEOARTHRITISP20RR016458 · NCRR · UNIVERSITY OF DELAWARE · PI RUDOLPH, KATHERINE S · 2002 to 2011
$18.9M
ACL Injured Knee: MRI and Biomechanical ModelingR01AR046386 · NIAMS · UNIVERSITY OF DELAWARE · PI BUCHANAN, THOMAS S · 1999 to 2011
$2.8M
Biochemistry of Uterine Heparan Sulfate ReceptorsR37HD025235 · NICHD · UNIVERSITY OF DELAWARE · PI CARSON, DANIEL D. · 2002 to 2006
$1.5M
PERLECAN AND CHONDROGENESISR01DE013542 · NIDCR · UNIVERSITY OF DELAWARE · PI CARSON, DANIEL D. · 2001 to 2004
$1.1M
NCI NIH HHS P01 CA098912NCRR NIH HHS P20 RR016458NIAMS NIH HHS R01 AR046386NICHD NIH HHS R37 HD025235NICHD NIH HHS R37 HD25235NIDCR NIH HHS R01 DE013542NIDCR NIH HHS R01 DE13542OCPHP CDC HHS P20 PR16458OCPHP CDC HHS P20-PR16458
6 · The paper itself

Abstract

Perlecan/HSPG2 is a large, multi-domain, multifunctional heparan sulfate proteoglycan with a wide tissue distribution. With the exception of its unique domain I, each of perlecan's other four domains shares sequence similarity to other protein families including low density lipoprotein (LDL) receptor, laminin alpha chain, neural cell adhesion molecule (NCAM), immunoglobulin (Ig) superfamily members, and epidermal growth factor (EGF). Previous studies demonstrated that glycosaminoglycan-bearing perlecan domain I supports early chondrogenesis and growth factor delivery. Other sites in the core protein interact with other matrix molecules and support cell adhesion, although the peptide sequences involved remain unidentified. To identify novel functional motifs within perlecan, we used a bioinformatics approach to predict regions likely to be on the exterior of the folded protein. Unique hydrophilic sequences of about 18 amino acids were selected for testing in cell adhesion assays. A novel peptide sequence (TWSKVGGHLRPGIVQSG) from an immunoglobulin (Ig) repeat in domain IV supported rapid cell adhesion, spreading and focal adhesion kinase (FAK) activation when compared to other peptides, a randomly scrambled sequence of the domain IV peptide or a negative control protein. MG-63 human osteosarcoma cells, epithelial cells and multipotent C(3)H10T1/2 cells, but not bone marrow cells, rapidly, i.e., within 30 min, formed focal adhesions and assembled an actin cytoskeleton on domain IV peptide. Cell lines differentially adhered to the domain IV peptide, suggesting adhesion is receptor specific. Adhesion was divalent cation independent and heparin sensitive, a finding that may explain some previously poorly understood observations obtained with intact perlecan. Collectively, these studies demonstrate the feasibility of using bioinformatics-based strategies to identify novel functional motifs in matrix proteins such as perlecan.

Indexed as

Protein Structure, TertiaryAmino Acid SequenceAnimalsAntibodiesCations, DivalentCell AdhesionCell LineCell Line, TumorCell MovementComputational BiologyCytoskeletonEnzyme ActivationFibroblastsFocal Adhesion Kinase 1Heparan Sulfate ProteoglycansHeparinAntibodiesCations, DivalentFocal Adhesion Kinase 1Heparan Sulfate ProteoglycansHeparinIntegrin beta1Peptide FragmentsperlecanPtk2 protein, mouseSerum Albumin, Bovine

Identifiers

PMID17997086
PMCPMC2276179
OpenAlexW1967814530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.